Neurocrine Biosciences reported $25.5M in Stock for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 14.34M 3.55M
Adamas Pharmaceuticals ADMS:US 8.68M 892K
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
ALKERMES ALKS:US $ 138.7M 2.62M
Alnylam Pharmaceuticals ALNY:US $ 110.95M 26.59M
Amgen AMGN:US $ 4152M 37M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 749.41M 38.43M
Dynavax Technologies DVAX:US $ 67.3M 19.15M
Exelixis EXEL:US $ 28.24M 3.26M
Gilead Sciences GILD:US $ 2797M 191M
Halozyme Therapeutics HALO:US $ 55.98M 2.58M
Intra Cellular Therapies ITCI:US $ 8.17M 0.4M
IONIS PHARMACEUT IONS:US $ 22.93M 1.17M
Nektar Therapeutics NKTR:US $ 15.33M 0.71M
Neurocrine Biosciences NBIX:US $ 25.5M 2.8M
Regeneron Pharmaceuticals REGN:US $ 1550.1M 433.8M
Repligen RGEN:US $ 156.16M 20.65M
Teva Pharmaceutical TEVA:IT 4.17B 195M
Ultragenyx Pharmaceutical RARE:US $ 15.19M 0.11M
Vertex Pharmaceuticals VRTX:US $ 333.46M 11.84M
YTE INCY:US $ 21.3M 4.63M
Zogenix ZGNX:US $ 3.5M 0.58M